Related Experiment Video
Updated: Jan 31, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Treatment Delayed is Treatment Denied
Jhilam Biswas1, Eric Y Drogin2, Thomas G Gutheil2
1Dr. Biswas is the Director of Psychiatry, Law and Society, Department of Psychiatry, Brigham and Women's Hospital, Boston, MA and a forensic psychiatrist in the Department of Psychiatry, Bridgewater State Hospital, MA. Dr. Drogin is a lecturer, Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Dr. Gutheil is Professor of Psychiatry, Department of Psychiatry, Beth Israel Deaconess Medical Center and the Massachusetts Mental Health Center, Harvard Medical School, Boston, MA. jbiswas@bwh.harvard.edu.
Abstract:
The past few decades have witnessed the steady development of a mental health jurisprudence dedicated to the preservation of human rights. Self-determination and personal autonomy are critical aspects of this perspective, pervading every facet of institutional psychiatric care. Of considerable concern, however, are those cases in which rote procedural approaches produce unintended consequences for the very persons such maneuvers were designed to protect. Delays-inherent in court-based procedures-may ironically lead to an acute illness becoming chronic, and to a single bout of inpatient services being transformed into a lifetime of revolving-door psychiatric admissions. This discussion is not about lawyers or lawyering; rather, it is about the proposition that a better system can and should be devised for advocates who must make do with the options they are dealt. A particularly problematic example is the "Rogers Guardianship" model currently prevalent in Massachusetts. Laws that effectively place on counsel and courts the challenge of second-guessing medical treatment decisions-with minimal latitude for counsel to exercise measured professional judgment-will inevitably generate, and empirically do generate, a degree of delay that ironically deprives patients of the liberation from illness that is the common goal of all stakeholders. Possible solutions to these difficulties are also suggested.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Treatment Resistant Cancers
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Angle Closure Glaucoma: Treatment

